Dymista Allergen Chamber - Onset of Action Study

Clinical trial NCT04652245 · COMPLETED

Trial details

NCT number: NCT04652245
Sponsor: MEDA Pharma GmbH & Co. KG
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Seasonal Allergic Rhinitis

Start date: 2020-12-14
Primary completion: 2021-12-04
Enrollment: 216

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.